Trial intelligence / Profile preview

Remimazolam vs Desflurane for Arrhythmia Ablation Anesthesia

NCT05486377Phase 4Completed

Sponsor
Seoul National University Bundang Hospital
Start
Aug 2022
Primary completion
May 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of remimazolam in cardiac arrhythmia, sponsored by Seoul National University Bundang Hospital. Started Aug 2022; status: completed.

02

Drugs

remimazolam
03

Conditions

cardiac arrhythmia

Beyond the preview

Go deeper on NCT05486377.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05486377.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call